Showing 491-500 of 2392 results for "".
Hyperkinetic Movement Disorders
https://practicalneurology.com/diseases-diagnoses/movement-disorders/hyperkinetic-movement-disorders/30248/New treatments were approved in 2017 for tardive dyskinesia, Parkinson's dyskinesia, and Huntington's chorea.Calcitonin Gene-Related Peptide Monoclonal Antibodies
https://practicalneurology.com/diseases-diagnoses/headache-pain/calcitonin-gene-related-peptide-monoclonal-antibodies/30275/A new treatment for managing migraine in the clinic is on the horizon.Why Neuroimaging Plays a Critical Role in Shaping the Future of Neurology
https://practicalneurology.com/diseases-diagnoses/imaging-testing/viewpoints-why-neuroimaging-plays-a-critical-role-in-shaping-the-future-of-neurology/30403/An integral part of clinical neurology and neurosciences, neuroimaging training must be better harnessed and incorporated into the educational spectrum of the specialty.Spontaneous Intracranial Hypotension
https://practicalneurology.com/diseases-diagnoses/headache-pain/spontaneous-intracranial-hypotension/30662/Spontaneous intracranial hypotension remains an underdiagnosed etiology of new-onset headache.- Letters to the Editor: The tPA Debate Continues: “Dr. Anonymous” Respondshttps://practicalneurology.com/columns/practice-management/letters-to-the-editor-the-tpa-debate-continues-dr-anonymous-responds/31488/Ongoing Debate on tPA Use in Acute Stroke ManagementAn anonymous physician from Oklahoma responds to prior discussions on the use of tissue plasminogen activator (tPA) in acute stroke treatment, emphasizing a cautious approach grounded in ethical and practical considerations. The physician clarifies
Treatment of Movement Disorders with Neuromodulation
https://practicalneurology.com/diseases-diagnoses/movement-disorders/treatment-of-movement-disorders-with-neuromodulation/32040/Effective surgical treatments are available for Parkinson disease, essential tremor, and dystonia.- Epilepsy Essentialshttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/PN0708Epilepsy-pdf/31003/Complementary and Alternative Medical Therapies (CAMs) are increasingly utilized by patients with epilepsy, highlighting the necessity for healthcare professionals to be vigilant about their potential impacts. CAMs encompass a variety of treatments, including herbal medicines, dietary supplements, a
- Editorial Board & Contributorshttps://practicalneurology.com/columns/practice-management/editorial-board-contributors/31058/The January 2008 issue of *Practical Neurology* features a distinguished editorial board and contributor lineup, underscoring the journal’s commitment to advancing neurological medicine. Led by Dr. Stephen Gollomp, Chief of Neurology at Lankenau Hospital and Clinical Professor at Thomas Jefferson Un
- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31191/Advancements in Neurology: Key Developments in Epilepsy Management and BeyondRecent breakthroughs in epilepsy care are equipping neurologists with enhanced therapeutic options and optimizing existing treatments. A pivotal study published in the April 10th issue of *Neurology* highlights the efficacy
- Epilepsy Essentialshttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/PN1206Epilepsy-pdf/31237/The Role of Generic Antiepileptic Drugs in Epilepsy ManagementEffective epilepsy treatment aims to achieve seizure freedom without adverse side effects. According to Kwan and Brodie, approximately 64% of patients reach this goal using either monotherapy or a combination of two antiseizure medication